This presentation has some interesting info in relation to the approval of the Amylyx ALS/MND drug AMX0035 and the competition in general. There is a long way to go but compared to what is out there MPL is looking great IMO. A couple of extracts below:
Full Presentation:
https://www.fda.gov/media/161433/download
A lot to wade through but there is interesting info in there on biomarker baselines and the Functional Rating Scales, which may be of some use for some people for comparisons to MPL as more data emerges.
This presentation has some interesting info in relation to the...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $96.77M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $47.37K | 197.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 27970 | 3 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
0.005 ( 2.77 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 24.5¢ | 24.0¢ | 93977 | ||
| Last updated 15.00pm 29/04/2024 ? | |||||
| PAA (ASX) Chart |